| Primary |
| Tuberculosis |
33.8% |
| Pulmonary Tuberculosis |
25.1% |
| Tuberculosis Of Eye |
5.7% |
| Latent Tuberculosis |
4.0% |
| Meningitis Tuberculous |
3.8% |
| Lymph Node Tuberculosis |
3.4% |
| Antibiotic Prophylaxis |
3.2% |
| Disseminated Tuberculosis |
3.2% |
| Tuberculin Test Positive |
2.6% |
| Tuberculous Pleurisy |
2.1% |
| Drug Use For Unknown Indication |
1.9% |
| Intermediate Uveitis |
1.7% |
| Peritoneal Tuberculosis |
1.5% |
| Tuberculosis Skin Test Positive |
1.5% |
| Choroiditis |
1.4% |
| Immunosuppression |
1.4% |
| Uveitis |
1.2% |
| Extrapulmonary Tuberculosis |
0.9% |
| Product Used For Unknown Indication |
0.8% |
| Tuberculosis Gastrointestinal |
0.8% |
|
| Vomiting |
16.1% |
| Death |
7.8% |
| Pyrexia |
7.3% |
| Toxic Epidermal Necrolysis |
6.3% |
| Hepatitis |
5.9% |
| Paradoxical Drug Reaction |
5.9% |
| Rash |
5.4% |
| Jaundice |
4.9% |
| Nausea |
4.9% |
| Tuberculoma Of Central Nervous System |
4.9% |
| Asthma |
4.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.9% |
| Tuberculosis |
3.9% |
| Liver Function Test Abnormal |
2.9% |
| Liver Injury |
2.9% |
| Weight Decreased |
2.9% |
| Acute Hepatic Failure |
2.4% |
| Hepatotoxicity |
2.4% |
| Psychiatric Symptom |
2.4% |
| Rash Erythematous |
2.4% |
|
| Secondary |
| Tuberculosis |
25.3% |
| Pulmonary Tuberculosis |
19.7% |
| Rheumatoid Arthritis |
8.8% |
| Hiv Infection |
8.3% |
| Product Used For Unknown Indication |
5.7% |
| Prophylaxis |
5.1% |
| Drug Use For Unknown Indication |
4.9% |
| Psoriasis |
3.4% |
| Tuberculosis Of Eye |
2.7% |
| Disseminated Tuberculosis |
2.7% |
| Antibiotic Prophylaxis |
2.3% |
| Lymph Node Tuberculosis |
2.0% |
| Hypertension |
1.9% |
| Meningitis Tuberculous |
1.7% |
| Renal Transplant |
1.2% |
| Ankylosing Spondylitis |
1.1% |
| Tuberculous Pleurisy |
1.0% |
| Retinal Vasculitis |
0.8% |
| Antiretroviral Therapy |
0.7% |
| Choroiditis |
0.7% |
|
| Vomiting |
13.9% |
| Liver Disorder |
8.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
7.2% |
| Tuberculosis |
6.5% |
| Pyrexia |
6.3% |
| Hepatic Function Abnormal |
5.7% |
| Hepatitis |
5.3% |
| Hepatotoxicity |
4.4% |
| Interstitial Lung Disease |
4.2% |
| Acute Hepatic Failure |
3.8% |
| Weight Decreased |
3.8% |
| Lymph Node Tuberculosis |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Renal Failure Acute |
3.6% |
| Spermatozoa Progressive Motility Decreased |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.4% |
| Renal Failure |
3.2% |
| Neutropenia |
2.9% |
| Jaundice |
2.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
29.0% |
| Product Used For Unknown Indication |
13.0% |
| Prophylaxis |
8.4% |
| Drug Use For Unknown Indication |
7.9% |
| Tuberculosis |
7.1% |
| Hiv Infection |
6.9% |
| Antibiotic Prophylaxis |
6.7% |
| Pulmonary Tuberculosis |
3.4% |
| Hypertension |
2.9% |
| Osteoporosis |
2.3% |
| Psoriasis |
2.3% |
| Crohn's Disease |
1.5% |
| Psoriatic Arthropathy |
1.4% |
| Ankylosing Spondylitis |
1.2% |
| Colitis Ulcerative |
1.1% |
| Insomnia |
1.1% |
| Behcet's Syndrome |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Gastritis Prophylaxis |
0.9% |
| Pain |
0.8% |
|
| Vomiting |
14.9% |
| Pyrexia |
10.1% |
| Tuberculosis |
8.9% |
| Pneumonia |
6.7% |
| Weight Decreased |
6.2% |
| Pulmonary Tuberculosis |
6.0% |
| Interstitial Lung Disease |
5.9% |
| Respiratory Failure |
4.5% |
| White Blood Cell Count Decreased |
4.0% |
| Sepsis |
3.9% |
| Renal Failure |
3.8% |
| Pneumocystis Jiroveci Pneumonia |
3.7% |
| Death |
3.5% |
| Immune Reconstitution Syndrome |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Subarachnoid Haemorrhage |
2.7% |
| Septic Shock |
2.5% |
| Rash |
2.4% |
| Tuberculin Test Positive |
2.4% |
| Hepatitis |
2.3% |
|
| Interacting |
| Tuberculosis |
24.8% |
| Disseminated Tuberculosis |
11.4% |
| Pulmonary Tuberculosis |
8.4% |
| Stem Cell Transplant |
7.9% |
| Tuberculin Test Positive |
5.9% |
| Rheumatoid Arthritis |
5.4% |
| Hiv Infection |
5.0% |
| Bone Tuberculosis |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Latent Tuberculosis |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Hypertension |
2.5% |
| Premedication |
2.5% |
| Antiretroviral Therapy |
2.0% |
| Combined Immunodeficiency |
2.0% |
| Depression |
2.0% |
| Renal Transplant |
2.0% |
| Antibiotic Prophylaxis |
1.5% |
| Epilepsy |
1.5% |
| Hypercholesterolaemia |
1.5% |
|
| Drug Interaction |
19.2% |
| Serotonin Syndrome |
11.5% |
| Optic Neuritis |
9.6% |
| Vomiting |
7.7% |
| Hepatocellular Injury |
5.8% |
| Weight Decreased |
5.8% |
| Coronary Artery Disease |
3.8% |
| Hepatic Failure |
3.8% |
| Liver Disorder |
3.8% |
| Nausea |
3.8% |
| Pyrexia |
3.8% |
| Tachypnoea |
3.8% |
| Tuberculin Test Positive |
3.8% |
| Blood Alkaline Phosphatase Increased |
1.9% |
| Coma |
1.9% |
| Discomfort |
1.9% |
| Grand Mal Convulsion |
1.9% |
| Hepatic Enzyme Increased |
1.9% |
| Hepatitis B Surface Antigen Positive |
1.9% |
| Hepatitis Cholestatic |
1.9% |
|
